HIV-1/2 differentiation in a South African public laboratory

Background: The human immunodeficiency virus type-2 (HIV-2) prevalence in South Africa (SA) is unknown, however, sporadic cases have been reported. Human immunodeficiency virus -1 and 2 differentiation is not part of most South African public laboratories’ testing algorithm. Human immunodeficiency v...

Full description

Bibliographic Details
Main Authors: Rendani T. Mafuyeka, Lynne M. Webber, Piet Becker, Simnikiwe H. Mayaphi
Format: Article
Language:English
Published: AOSIS 2021-03-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1185
_version_ 1817984624168534016
author Rendani T. Mafuyeka
Lynne M. Webber
Piet Becker
Simnikiwe H. Mayaphi
author_facet Rendani T. Mafuyeka
Lynne M. Webber
Piet Becker
Simnikiwe H. Mayaphi
author_sort Rendani T. Mafuyeka
collection DOAJ
description Background: The human immunodeficiency virus type-2 (HIV-2) prevalence in South Africa (SA) is unknown, however, sporadic cases have been reported. Human immunodeficiency virus -1 and 2 differentiation is not part of most South African public laboratories’ testing algorithm. Human immunodeficiency virus -2 diagnosis using serology assays may be complicated by HIV-1 and HIV-2 antibody cross-reactivity. Objectives: To determine the proportion of HIV-2 infections in specimens that tested HIV-1/2 positive at a public laboratory in Tshwane. Method: A total of 480 specimens that were previously tested with fourth generation ELISA platforms (Modular E170 [Roche, Switzerland] and Architect i2000 [Abbott, Germany]) were randomly selected. Human immunodeficiency virus -1 and 2 antibody differentiation testing was carried out using the Multispot HIV-1/2 rapid assay (Bio-Rad Laboratories, USA). An in-house nested HIV-2 PCR assay targeting the 5′-long terminal repeats (5′-LTR) region was evaluated and used as a confirmatory test. Results: The study tested 480 HIV-1/2 seropositive patients and their mean age was 36.7 years (range 3–82 years). Of the 480 patients, 292 (60.8%) were female, 182 (37.9%) were male and 6 (1.3%) were not specified. Human immunodeficiency virus differentiation results were as follows: 466 (97.1%) were positive for only HIV-1 antibodies, 11 (2.3%) [95%CI: (0.98%; 3.74%)] were positive for both HIV-1 and HIV-2 antibodies, 3 (0.6%) were negative for both antibodies and none were positive for only HIV-2 antibodies. Of the 11 specimens with both HIV-1 and HIV-2 antibodies, seven had sufficient volume for confirmatory testing and were all negative on the in-house HIV-2 PCR assay. Conclusion: The multispot HIV-1/2 rapid assay demonstrated cross-reactivity between HIV-1 and HIV-2 antibodies. Human immunodeficiency virus -2 infections were not detected.
first_indexed 2024-04-13T23:47:26Z
format Article
id doaj.art-6f78cd5f2a1646ab9a399f80ac08e4f1
institution Directory Open Access Journal
issn 1608-9693
2078-6751
language English
last_indexed 2024-04-13T23:47:26Z
publishDate 2021-03-01
publisher AOSIS
record_format Article
series Southern African Journal of HIV Medicine
spelling doaj.art-6f78cd5f2a1646ab9a399f80ac08e4f12022-12-22T02:24:15ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512021-03-01221e1e710.4102/sajhivmed.v22i1.1185737HIV-1/2 differentiation in a South African public laboratoryRendani T. Mafuyeka0Lynne M. Webber1Piet Becker2Simnikiwe H. Mayaphi3Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, PretoriaDepartment of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria; Department of Virology, Tshwane Academic division, National Health Laboratory, PretoriaResearch Office, Faculty of Health Sciences, University of Pretoria, PretoriaDepartment of Medical Virology, Faculty of Health Sciences, University of Pretoria, PretoriaBackground: The human immunodeficiency virus type-2 (HIV-2) prevalence in South Africa (SA) is unknown, however, sporadic cases have been reported. Human immunodeficiency virus -1 and 2 differentiation is not part of most South African public laboratories’ testing algorithm. Human immunodeficiency virus -2 diagnosis using serology assays may be complicated by HIV-1 and HIV-2 antibody cross-reactivity. Objectives: To determine the proportion of HIV-2 infections in specimens that tested HIV-1/2 positive at a public laboratory in Tshwane. Method: A total of 480 specimens that were previously tested with fourth generation ELISA platforms (Modular E170 [Roche, Switzerland] and Architect i2000 [Abbott, Germany]) were randomly selected. Human immunodeficiency virus -1 and 2 antibody differentiation testing was carried out using the Multispot HIV-1/2 rapid assay (Bio-Rad Laboratories, USA). An in-house nested HIV-2 PCR assay targeting the 5′-long terminal repeats (5′-LTR) region was evaluated and used as a confirmatory test. Results: The study tested 480 HIV-1/2 seropositive patients and their mean age was 36.7 years (range 3–82 years). Of the 480 patients, 292 (60.8%) were female, 182 (37.9%) were male and 6 (1.3%) were not specified. Human immunodeficiency virus differentiation results were as follows: 466 (97.1%) were positive for only HIV-1 antibodies, 11 (2.3%) [95%CI: (0.98%; 3.74%)] were positive for both HIV-1 and HIV-2 antibodies, 3 (0.6%) were negative for both antibodies and none were positive for only HIV-2 antibodies. Of the 11 specimens with both HIV-1 and HIV-2 antibodies, seven had sufficient volume for confirmatory testing and were all negative on the in-house HIV-2 PCR assay. Conclusion: The multispot HIV-1/2 rapid assay demonstrated cross-reactivity between HIV-1 and HIV-2 antibodies. Human immunodeficiency virus -2 infections were not detected.https://sajhivmed.org.za/index.php/hivmed/article/view/1185hiv-1/2 differentiationhiv-2 testinghiv1/2 antibody cross reactionhiv-2 in south africahiv-2 pcr
spellingShingle Rendani T. Mafuyeka
Lynne M. Webber
Piet Becker
Simnikiwe H. Mayaphi
HIV-1/2 differentiation in a South African public laboratory
Southern African Journal of HIV Medicine
hiv-1/2 differentiation
hiv-2 testing
hiv1/2 antibody cross reaction
hiv-2 in south africa
hiv-2 pcr
title HIV-1/2 differentiation in a South African public laboratory
title_full HIV-1/2 differentiation in a South African public laboratory
title_fullStr HIV-1/2 differentiation in a South African public laboratory
title_full_unstemmed HIV-1/2 differentiation in a South African public laboratory
title_short HIV-1/2 differentiation in a South African public laboratory
title_sort hiv 1 2 differentiation in a south african public laboratory
topic hiv-1/2 differentiation
hiv-2 testing
hiv1/2 antibody cross reaction
hiv-2 in south africa
hiv-2 pcr
url https://sajhivmed.org.za/index.php/hivmed/article/view/1185
work_keys_str_mv AT rendanitmafuyeka hiv12differentiationinasouthafricanpubliclaboratory
AT lynnemwebber hiv12differentiationinasouthafricanpubliclaboratory
AT pietbecker hiv12differentiationinasouthafricanpubliclaboratory
AT simnikiwehmayaphi hiv12differentiationinasouthafricanpubliclaboratory